GlobeNewswire Inc.··Nanobiotix Communications DepartmentNanobiotix's Nanoprimer Shows Promise in Reducing LNP Toxicity, Boosting Drug Delivery
Nanobiotix presented preclinical data showing its Nanoprimer platform reduces liver toxicity and improves bioavailability of LNP-delivered DNA immunotherapies in mouse models.
NBTXNanotechnologybioavailability